| Shakthi Nandan Sureddi, MD | |
|
47 New Scotland Avenue, Dept. Of Neurology, Albany, NY 12208-3412 | |
| (518) 262-6488 | |
| Not Available |
| Full Name | Shakthi Nandan Sureddi |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Neurology |
| Location | 47 New Scotland Avenue, Dept. Of Neurology, Albany, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114421336 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 318288 (New York) | Primary |
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629008537 PECOS PAC ID: 1759293111 Enrollment ID: O20031125000386 |
News Archive
There's an app for everything these days-from weight loss to working out. Now, thanks in part to support from the Office of Naval Research, there's an app that may screen for autism by reading kids' facial expressions for emotional cues.
The American Telemedicine Association (ATA) has called on the Centers for Medicare and Medicaid Services (CMS) to use its authority to waive the restriction-riddled Medicare telemedicine statute for the new Accountable Care Organizations (ACOs).
Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This "nanosponge vaccine" enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA-both within the bloodstream and on the skin. Nanoengineers from the University of California, San Diego described the safety and efficacy of this nanosponge vaccine in the December 1 issue of Nature Nanotechnology.
Sinapis Pharma is pleased to announce that it has received notice from the FDA that its Investigational New Drug application (IND) for the use of IV methamphetamine for acute stroke was approved on April 9, 2010. "We have accomplished a great deal of work for a small company on a very tight budget. We have GMP drug ready for the Phase I clinical trial and the Phase I site is prepared to begin this protocol," said Dr. Donald Picker , the company CEO.
A new classification system that scores the variables associated with mortality rates for patients who develop intra-abdominal sepsis after surgery may help guide care and improve outcomes
› Verified 9 days ago
| Entity Name | Delaware Valley Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144312646 PECOS PAC ID: 2860388337 Enrollment ID: O20040223001307 |
News Archive
There's an app for everything these days-from weight loss to working out. Now, thanks in part to support from the Office of Naval Research, there's an app that may screen for autism by reading kids' facial expressions for emotional cues.
The American Telemedicine Association (ATA) has called on the Centers for Medicare and Medicaid Services (CMS) to use its authority to waive the restriction-riddled Medicare telemedicine statute for the new Accountable Care Organizations (ACOs).
Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This "nanosponge vaccine" enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA-both within the bloodstream and on the skin. Nanoengineers from the University of California, San Diego described the safety and efficacy of this nanosponge vaccine in the December 1 issue of Nature Nanotechnology.
Sinapis Pharma is pleased to announce that it has received notice from the FDA that its Investigational New Drug application (IND) for the use of IV methamphetamine for acute stroke was approved on April 9, 2010. "We have accomplished a great deal of work for a small company on a very tight budget. We have GMP drug ready for the Phase I clinical trial and the Phase I site is prepared to begin this protocol," said Dr. Donald Picker , the company CEO.
A new classification system that scores the variables associated with mortality rates for patients who develop intra-abdominal sepsis after surgery may help guide care and improve outcomes
› Verified 9 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629491329 PECOS PAC ID: 1759293111 Enrollment ID: O20140617000347 |
News Archive
There's an app for everything these days-from weight loss to working out. Now, thanks in part to support from the Office of Naval Research, there's an app that may screen for autism by reading kids' facial expressions for emotional cues.
The American Telemedicine Association (ATA) has called on the Centers for Medicare and Medicaid Services (CMS) to use its authority to waive the restriction-riddled Medicare telemedicine statute for the new Accountable Care Organizations (ACOs).
Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This "nanosponge vaccine" enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA-both within the bloodstream and on the skin. Nanoengineers from the University of California, San Diego described the safety and efficacy of this nanosponge vaccine in the December 1 issue of Nature Nanotechnology.
Sinapis Pharma is pleased to announce that it has received notice from the FDA that its Investigational New Drug application (IND) for the use of IV methamphetamine for acute stroke was approved on April 9, 2010. "We have accomplished a great deal of work for a small company on a very tight budget. We have GMP drug ready for the Phase I clinical trial and the Phase I site is prepared to begin this protocol," said Dr. Donald Picker , the company CEO.
A new classification system that scores the variables associated with mortality rates for patients who develop intra-abdominal sepsis after surgery may help guide care and improve outcomes
› Verified 9 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497921688 PECOS PAC ID: 1759293111 Enrollment ID: O20190320001621 |
News Archive
There's an app for everything these days-from weight loss to working out. Now, thanks in part to support from the Office of Naval Research, there's an app that may screen for autism by reading kids' facial expressions for emotional cues.
The American Telemedicine Association (ATA) has called on the Centers for Medicare and Medicaid Services (CMS) to use its authority to waive the restriction-riddled Medicare telemedicine statute for the new Accountable Care Organizations (ACOs).
Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This "nanosponge vaccine" enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA-both within the bloodstream and on the skin. Nanoengineers from the University of California, San Diego described the safety and efficacy of this nanosponge vaccine in the December 1 issue of Nature Nanotechnology.
Sinapis Pharma is pleased to announce that it has received notice from the FDA that its Investigational New Drug application (IND) for the use of IV methamphetamine for acute stroke was approved on April 9, 2010. "We have accomplished a great deal of work for a small company on a very tight budget. We have GMP drug ready for the Phase I clinical trial and the Phase I site is prepared to begin this protocol," said Dr. Donald Picker , the company CEO.
A new classification system that scores the variables associated with mortality rates for patients who develop intra-abdominal sepsis after surgery may help guide care and improve outcomes
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shakthi Nandan Sureddi, MD 47 New Scotland Avenue, Dept. Of Neurology, Albany, NY 12208-3412 Ph: (518) 262-6488 | Shakthi Nandan Sureddi, MD 47 New Scotland Avenue, Dept. Of Neurology, Albany, NY 12208-3412 Ph: (518) 262-6488 |
News Archive
There's an app for everything these days-from weight loss to working out. Now, thanks in part to support from the Office of Naval Research, there's an app that may screen for autism by reading kids' facial expressions for emotional cues.
The American Telemedicine Association (ATA) has called on the Centers for Medicare and Medicaid Services (CMS) to use its authority to waive the restriction-riddled Medicare telemedicine statute for the new Accountable Care Organizations (ACOs).
Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This "nanosponge vaccine" enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA-both within the bloodstream and on the skin. Nanoengineers from the University of California, San Diego described the safety and efficacy of this nanosponge vaccine in the December 1 issue of Nature Nanotechnology.
Sinapis Pharma is pleased to announce that it has received notice from the FDA that its Investigational New Drug application (IND) for the use of IV methamphetamine for acute stroke was approved on April 9, 2010. "We have accomplished a great deal of work for a small company on a very tight budget. We have GMP drug ready for the Phase I clinical trial and the Phase I site is prepared to begin this protocol," said Dr. Donald Picker , the company CEO.
A new classification system that scores the variables associated with mortality rates for patients who develop intra-abdominal sepsis after surgery may help guide care and improve outcomes
› Verified 9 days ago
Dr. Stanley F Penc, MD PHD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 400 Patroon Creek Blvd, Suite 210, Albany, NY 12206 Phone: 518-459-8106 | |
Dr. Donald Stone Higgins Jr., M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 113 Holland Ave, Neurology Service (127), Albany, NY 12208 Phone: 518-626-6391 Fax: 518-626-6369 | |
Dr. Christopher John Hanowitz, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave, Department Of Emergency Medicine, Albany, NY 12208 Phone: 518-262-3095 | |
Daniel Gabriels, Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 75 New Scotland Ave, Albany, NY 12208 Phone: 518-447-9611 | |
Ryan Patrick Bochacki, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 113 Holland Ave, Albany, NY 12208 Phone: 518-626-5991 | |
Dr. Amanda Jane Crosier-riffle, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-525-1303 | |
Robert F. Malerba Ii, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 732 Madison Ave, Albany, NY 12208 Phone: 518-436-0874 |